GAF Healthcare
Specialty Overview

Best Hospitals for Stem Cell Therapy in Mumbai, India

17 hematology hospitals in our India network are listed in Mumbai, accredited by JCI, NABH, NABL, ISO 9001, with 6,503 beds combined.

17
Hospitals Listed
1
City
4.6
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the hematology hospitals in our directory offering Stem Cell Therapy in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Nanavati Super Specialty Hospital🇮🇳 Kokilaben Dhirubhai Ambani Hospital🇮🇳 Tata Memorial Hospital

Ask us about stem cell therapy in Mumbai, India

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for Stem Cell Therapy in Mumbai, India

Nanavati Super Specialty Hospital Featured

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviews350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatricsStem Cell Therapy
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Enquire NowView Profile
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular SurgeryStem Cell Therapy
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Enquire NowView Profile
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviews629 beds
Specialties & Accreditation
OncologyCancer CenterStem Cell Therapy
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Enquire NowView Profile
Apollo Hospitals, Navi Mumbai

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 512 reviews500 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine SurgeryStem Cell Therapy
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.8/5
Rating
2016
Established
500
Beds
Mumbai, India
Location
Enquire NowView Profile
Gleneagles Hospital, Mumbai

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 reviews) 638 beds
Why consider this hospital?
4.8/5 rating from 615 reviews638 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterologyStem Cell Therapy
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.8/5
Rating
2008
Established
638
Beds
Mumbai, India
Location
Enquire NowView Profile
Lilavati Hospital And Research Centre

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 reviews) 326 beds
Why consider this hospital?
4.8/5 rating from 724 reviews326 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterologyStem Cell Therapy
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.8/5
Rating
1997
Established
326
Beds
Mumbai, India
Location
Enquire NowView Profile
Jaslok Hospital

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 reviews) 350 beds
Why consider this hospital?
4.6/5 rating from 129 reviews350 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplantStem Cell Therapy
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation

Patients considering stem cell therapy can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.6/5
Rating
1973
Established
350
Beds
Mumbai, India
Location
Enquire NowView Profile
Gleneagles Global Hospitals (Global Hospitals)

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 reviews) 450 beds
Why consider this hospital?
4.6/5 rating from 183 reviews450 beds
Specialties & Accreditation
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciencesStem Cell Therapy
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation

Patients considering stem cell therapy can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.6/5
Rating
1996
Established
450
Beds
Parel, Mumbai, India
Location
Enquire NowView Profile
Medicover Hospital, Navi Mumbai

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 reviews) 310 beds
Why consider this hospital?
4.6/5 rating from 143 reviews310 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterologyStem Cell Therapy
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.6/5
Rating
2023
Established
310
Beds
Navi Mumbai, India
Location
Enquire NowView Profile
KIMS Hospitals, Thane

🇮🇳 KIMS Hospitals, Thane

Mumbai, India 4.6 (58 reviews) 300 beds
Why consider this hospital?
4.6/5 rating from 58 reviews300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine SurgeryStem Cell Therapy
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering stem cell therapy can be cared for by KIMS Hospitals, Thane's care team in Mumbai, India, from initial consultation through recovery. KIMS Hospitals, Thane, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.6/5
Rating
2025
Established
300
Beds
Mumbai, India
Location
Enquire NowView Profile

Top Hematology Doctors in Mumbai, India

Image not available Featured

Dr. Muralidaran C

MBBS, MD, DM (Clinical Hematology)
Consultant Hematologist & Bone Marrow Transplant Physician · Specialty: Hematologist & BMT Specialist
Wockhardt Hospital Mumbai, India9+ Years experience
Why consider this doctor?
  • 9+ years of experience in Hematologist & BMT Specialist
  • Consultant Hematologist & Bone Marrow Transplant Physician, Wockhardt Hospital, Mumbai — Present
  • Superspecialty Medical Officer, MCGM–CTC PHO BMT Centre, Mumbai
Expertise & Procedures
  • Bone Marrow Aspiration and Biopsy
  • Autologous Stem Cell Transplantation (ASCT)
  • Allogeneic Bone Marrow Transplantation
  • Haploidentical BMT with Haploidentical Donors
  • Lymph Node Fine Needle Aspiration Cytology (FNAC)
View all procedures →
Hematologist & BMT Specialist Experience: 9+ YearsHospital Affiliation: Wockhardt HospitalHospital accreditation: NABH, NABL
View Profile Book a Consultation
Image not available

Dr. Vipin Khandelwal

MBBS, MD (Paediatrics), DM (Paediatric Oncology), PDF (Paediatric Haematology & BMT)
Consultant — Paediatric Haematology, Oncology & Bone Marrow Transplantation · Specialty: Paediatric Haematologist & BMT Specialist
Apollo Hospitals Navi Mumbai, India12+ Years experience
Why consider this doctor?
  • 12+ years of experience in Paediatric Haematologist & BMT Specialist
  • Consultant — Paediatric Haematology, Oncology & Bone Marrow Transplantation, Apollo Hospitals, Navi Mumbai
  • Advanced training in Paediatric Haematology and Bone Marrow Transplantation
Expertise & Procedures
  • Paediatric Bone Marrow Transplantation (BMT)
  • Haploidentical Stem Cell Transplantation
  • Matched Sibling Donor Transplant
  • Matched Unrelated Donor Transplant
  • Autologous Stem Cell Transplantation
View all procedures →
Paediatric Haematologist & BMT Specialist Experience: 12+ YearsHospital Affiliation: Apollo HospitalsHospital accreditation: JCI, NABH
View Profile Book a Consultation
Our Methodology

How we selected these hospitals

A hospital appears on this page when Hematology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Stem Cell Therapy in Mumbai, India?

Choosing the right hospital for stem cell therapy is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include hematology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Stem Cell Therapy

Stem cell therapy is a cutting-edge regenerative medicine procedure that harnesses the body's own biological repair mechanisms — or those of a matched donor — to treat a spectrum of hematological malignancies, autoimmune disorders, and degenerative conditions, achieving disease remission or functional restoration in 60–80% of eligible patients depending on indication and protocol.

21–35 days (inpatient, including conditioning regimen and immediate post-transplant monitoring; autologous procedures may be shorter at 14–21 days)
Hospital Stay
6–12 weeks (fit-to-fly clearance depends on engraftment confirmation, absence of graft-versus-host disease, and stable absolute neutrophil count ≥ 500 cells/µL; allogeneic recipients typically require the longer end of this range)
Total Stay in Country (Fit-to-Fly)
60–80% (disease-free survival at 5 years varies by indication: ~80% for AML in first complete remission, ~65–70% for multiple myeloma post-autologous transplant, ~60% for aplastic anaemia post-allogeneic transplant)
Success Rate

Clinical Overview

  • Stem cell therapy — formally encompassing Haematopoietic Stem Cell Transplantation (HSCT), bone marrow transplantation (BMT), and emerging non-haematopoietic cellular therapies — works by replacing or supplementing a patient's damaged, malignant, or deficient cell populations with healthy progenitor cells capable of self-renewal and multi-lineage differentiation.
  • In haematological cancers such as acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), Hodgkin and non-Hodgkin lymphoma, and multiple myeloma, the diseased bone marrow is first ablated using high-dose chemotherapy (myeloablative conditioning, MAC) or reduced-intensity conditioning (RIC) regimens — commonly BEAM (carmustine, etoposide, cytarabine, melphalan) for lymphomas or Busulfan/Cyclophosphamide for AML — before healthy stem cells are infused intravenously and allowed to engraft within the marrow niches.
  • Beyond oncology, HSCT is an established curative option for non-malignant disorders including severe aplastic anaemia, sickle cell disease, beta-thalassaemia major, severe combined immunodeficiency (SCID), and Hurler syndrome, while mesenchymal stem cell (MSC) therapy is increasingly deployed in graft-versus-host disease (GvHD), Crohn's disease, and certain autoimmune conditions.
Full details →

Who is a Candidate?

  • IDEAL CANDIDATES — HAEMATOLOGICAL MALIGNANCIES:
  • Acute Myeloid Leukaemia (AML) in first or second complete remission (CR1/CR2), particularly intermediate- or high-risk cytogenetics per ELN 2022 classification
  • Acute Lymphoblastic Leukaemia (ALL) in CR1 (high-risk features: Philadelphia chromosome-positive [Ph+], MRD-positive) or CR2
  • Hodgkin Lymphoma relapsed/refractory after ≥2 lines of therapy, eligible for autologous HSCT
  • +29 more

Treatment Options & Approaches

  • AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (Auto-HSCT):

Recovery

  • PHASE 1 — REMOTE PRE-TRANSPLANT EVALUATION (4–8 weeks before travel):

Risks to be aware of

  • Stem cell therapy, particularly allogeneic HSCT, carries a significant risk profile that must be openly discussed with every patient before proceeding.
  • Treatment-related mortality (TRM) — death attributable to the procedure rather than underlying disease — ranges from 5–10% in matched sibling donor transplants at experienced centres to 15–20% in MUD or haploidentical transplants, and is higher in older patients and those with comorbidities, as quantified by the HCT-CI (Haematopoietic Cell Transplantation-specific Comorbidity Index) score.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, end-to-end patient support infrastructure designed specifically for international patients undergoing stem cell therapy in India or the UAE — managing every non-clinical element of the journey so that patients and their families can focus entirely on treatment and recovery.

Common questions about Stem Cell Therapy

What is the cost of Stem Cell Therapy in India versus the UAE?
The cost of stem cell therapy varies significantly by procedure type and destination. In India, the total cost ranges from approximately USD 18,000 to USD 55,000 — covering autologous HSCT (e.g., high-dose melphalan + stem cell rescue for multiple myeloma at the lower end) through full allogeneic matched unrelated donor (MUD) transplants with 30+ days of inpatient isolation (at the higher end). In the UAE (Dubai or Abu Dhabi), equivalent procedures typically cost between USD 40,000 and USD 110,000, reflecting higher facility overheads, luxury infrastructure, and operating costs in the Gulf. By comparison, the same allogeneic transplant in the United States costs USD 250,000–500,000, and in Germany or the UK, USD 120,000–200,000. Both India and the UAE offer JCI-accredited transplant centres with access to international donor registries (DKMS, NMDP), the same conditioning regimens (BuCy, BEAM, RIC fludarabine-based), and equivalent post-transplant monitoring technology. India's cost advantage (typically 40–60% lower than the UAE) makes it the most competitive destination globally for budget-conscious patients who do not compromise on quality. CAR-T cell therapy (e.g., tisagenlecleucel for B-ALL, axicabtagene ciloleucel for DLBCL) is available in both countries and generally costs USD 80,000–130,000 in India and USD 150,000–250,000 in the UAE — still a fraction of US pricing (USD 450,000+). GAF Healthcare provides a fully itemised cost estimate within 72 hours of medical record submission.
How long do I need to stay in the country before I am fit to fly home after stem cell therapy?
This is one of the most critical planning questions for international stem cell therapy patients, and the honest answer is: it is longer than for almost any other procedure. The minimum recommended in-country stay is 6 weeks post-transplant for autologous HSCT recipients (e.g., multiple myeloma or lymphoma patients), provided engraftment is confirmed (ANC > 500/µL on three consecutive days and platelet count > 20,000/µL independently), there is no active infection, and the patient is fully self-managing oral medications. For allogeneic HSCT recipients — including matched sibling, matched unrelated donor, and haploidentical transplants — the standard fit-to-fly window is 8 to 12 weeks post-transplant. This longer period is necessary to ensure stable engraftment is confirmed by STR-PCR chimerism testing, acute GvHD (if present) is controlled to Grade ≤ I on an acceptable oral immunosuppression regimen, CMV viral load is negative or stably suppressed, and the patient has been transitioned safely to an oral prophylactic regimen (tacrolimus or cyclosporine, letermovir, antifungal prophylaxis, acyclovir) that can be continued at home. Long-haul air travel is a particular concern for these patients due to hypoxic cabin air pressure, dehydration, and the risk of infectious exposure in airport environments; physicians at our partner centres issue detailed, personalised fit-to-fly certificates. GAF Healthcare arranges serviced apartment accommodation near the transplant centre for the entire outpatient monitoring phase, with private transport to all clinic appointments, so patients and families are fully supported throughout this period without needing to remain hospitalised.
What is the success rate of Stem Cell Therapy?
Success rates for stem cell therapy vary considerably based on the underlying condition being treated, disease stage at the time of transplant, patient age, performance status, and the type of transplant performed, so it is important to interpret any single figure with clinical context rather than as a universal promise. For the most common indications: Acute Myeloid Leukaemia (AML) in first complete remission (CR1) with favourable or intermediate-risk cytogenetics — 5-year disease-free survival (DFS) of 50–70% with matched sibling donor allogeneic HSCT; 40–60% with matched unrelated donor. AML in CR2 — 35–50% 5-year DFS. Acute Lymphoblastic Leukaemia (ALL) in CR1 (high-risk/Ph+) — 50–65% 5-year DFS; in CR2 — 35–55%. Multiple Myeloma post-autologous HSCT (following modern VRd or Dara-VRd induction) — progression-free survival (PFS) of 50–60% at 5 years; overall survival 70–80% at 5 years with modern maintenance lenalidomide. Hodgkin Lymphoma, autologous HSCT in chemosensitive relapse — 5-year PFS approximately 45–50%; with brentuximab vedotin maintenance, improved to 60–65%. Severe Aplastic Anaemia with matched sibling donor allogeneic HSCT in patients under 40 — overall survival of 80–90% at 5 years, representing a highly curative outcome. Beta-Thalassaemia Major (Pesaro Class I–II) with matched sibling donor — thalassaemia-free survival of 85–90% in young patients at expert centres. CAR-T therapy for relapsed/refractory B-ALL — complete remission rates of 70–90%, though durable remission without consolidative HSCT remains under study. These figures are benchmarked against EBMT registry data and are consistent with outcomes published by JCI-accredited centres in India and the UAE that partner with GAF Healthcare. Your transplant physician will provide personalised prognostic estimates based on your specific disease biology, HLA matching, and pre-transplant disease burden (including MRD status).

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Stem Cell Therapy in Mumbai, India

Discover the Top Hospitals for Stem Cell Therapy in Mumbai, India

This page lists 17 accredited hematology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about stem cell therapy in Mumbai, India

How many hematology hospitals are listed in Mumbai, India?
17 hospitals in our Mumbai, India directory are currently listed for hematology including Stem Cell Therapy.
How do you choose which hospitals to list?
A hospital appears on this page when Hematology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there hematology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for stem cell therapy?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about stem cell therapy in Mumbai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for stem cell therapy in Mumbai, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us